药学与临床研究
藥學與臨床研究
약학여림상연구
PHARMACEUTICAL AND CLINICAL RESEARCH
2014年
4期
365-367
,共3页
流感%奥司他韦%利巴韦林%疗效%不良反应
流感%奧司他韋%利巴韋林%療效%不良反應
류감%오사타위%리파위림%료효%불량반응
Influenza%Oseltamivir%Ribavirin%Clinical efficacy%Adverse reactions
目的:探讨奥司他韦抗病毒药治疗疑似甲流的安全性、有效性。方法:将60例疑似甲流患者随机平均分成2组:实验组口服奥司他韦治疗;对照组口服利巴韦林治疗。评估比较2组的流感症状缓解情况及症状消失时间。结果:实验组的临床有效率93.33%,明显高于对照组的70.00%(P<0.05)。实验组的退热时间以及其他主要症状平均消失时间明显短于对照组(P<0.05),实验组治疗5d后发热、咽喉痛、鼻塞、咳嗽、头痛、肌肉关节痛、发冷/出汗、乏力等症状的缓解率明显高于对照组(P<0.05);实验组的不良反应发生率13.33%,明显低于对照组36.67%(P<0.05)。结论:奥司他韦抗病毒用于治疗疑似甲流安全、有效,且效果好于利巴韦林。
目的:探討奧司他韋抗病毒藥治療疑似甲流的安全性、有效性。方法:將60例疑似甲流患者隨機平均分成2組:實驗組口服奧司他韋治療;對照組口服利巴韋林治療。評估比較2組的流感癥狀緩解情況及癥狀消失時間。結果:實驗組的臨床有效率93.33%,明顯高于對照組的70.00%(P<0.05)。實驗組的退熱時間以及其他主要癥狀平均消失時間明顯短于對照組(P<0.05),實驗組治療5d後髮熱、嚥喉痛、鼻塞、咳嗽、頭痛、肌肉關節痛、髮冷/齣汗、乏力等癥狀的緩解率明顯高于對照組(P<0.05);實驗組的不良反應髮生率13.33%,明顯低于對照組36.67%(P<0.05)。結論:奧司他韋抗病毒用于治療疑似甲流安全、有效,且效果好于利巴韋林。
목적:탐토오사타위항병독약치료의사갑류적안전성、유효성。방법:장60례의사갑류환자수궤평균분성2조:실험조구복오사타위치료;대조조구복리파위림치료。평고비교2조적류감증상완해정황급증상소실시간。결과:실험조적림상유효솔93.33%,명현고우대조조적70.00%(P<0.05)。실험조적퇴열시간이급기타주요증상평균소실시간명현단우대조조(P<0.05),실험조치료5d후발열、인후통、비새、해수、두통、기육관절통、발랭/출한、핍력등증상적완해솔명현고우대조조(P<0.05);실험조적불량반응발생솔13.33%,명현저우대조조36.67%(P<0.05)。결론:오사타위항병독용우치료의사갑류안전、유효,차효과호우리파위림。
To investigate the safety and effectiveness of antiviral oseltamivir for treatment of suspected influenza. Methods: The 60 cases of suspected influenza patients were randomly divided into two groups, control group (n=30) and treatment group (n=30). The control group was given ribavirin, and the treatment group was given oseltamivir. The remission and disappear time of influenza symptoms in the 2 groups were observed and compared. Results: The total efficiency rate was 93.33% vs 70.00% in the treatment group vs the control group(P<0.05); the time of temperature returned to normal and the disappear time of other influenza symptoms in the treatment group were significantly shorter than those in the control group (P<0.05); the symptoms remission rates of fever, sore throat, nasal congestion, cough, headache, muscle and joint pain, chills/sweats and fatigue in the treatment group after 5 days were significantly high-er than those in the control group (P<0.05); the incidence of adverse reactions was 13.33% vs 36.67% in the treatment group vs the control group (P<0.05). Conclusion: Antiviral oseltamivir for the treatment of suspected influenza is safe and effective.